Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Montana Business Press.
Press releases published on May 14, 2025
IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
·
May 14, 2025
Primary endpoint of pivotal Phase 3 trial (IOB-013/KN-D18) of lead investigational therapeutic cancer vaccine in patients with advanced melanoma still expected to readout in third quarter of 2025 Data presented at recent congresses reinforces the potential …
A comparative sNPWT study of 10,000+ C-sections shows PICO™ sNPWT reduces complications and cuts healthcare costs by $728,000 per 1,000 patients
GlobeNewswire
·
May 14, 2025
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces findings from a newly published comparative study of single-use Negative Pressure Wound Therapy (sNPWT) devices in Caesarean section (C-section) recovery has identified …
Technip Energies appoints Marco Tiziano Barone as Chief Legal Officer
GlobeNewswire
·
May 14, 2025
Technip Energies announces the appointment of Marco Tiziano Barone as Chief Legal Officer and member of the Group Executive Committee. In this role, he will oversee the Group’s Legal, Contracts and Compliance function. He succeeds Michael McGuinty, who has …
OxyCon Returns: The Flagship Web Scraping Conference Opens 2025 Registration
GlobeNewswire
·
May 14, 2025
VILNIUS, Lithuania, May 14, 2025 – Leading web intelligence collection platform Oxylabs announces registration start for the year's main event. OxyCon 2025, the annual free conference uniting industry experts from all over the world, is set for October 1. …
Technip Energies nomme Marco Tiziano Barone au poste de Directeur Juridique
GlobeNewswire
·
May 14, 2025
Technip Energies annonce la nomination de Marco Tiziano Barone en tant que Directeur Juridique et membre du Comité Exécutif du Groupe. A ce titre, il supervisera la fonction Juridique, Contrats et Conformité du Groupe. Il succède à Michael McGuinty, qui a …
Targeted Genomics Announces Commercial Collaboration with OraSure Technologies for Direct to Consumer (DTC) Celiac Genetic Testing
GlobeNewswire
·
May 14, 2025
IRVINE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Targeted Genomics LLC, developer of GlutenID, the first and only U.S. Food and Drug Administration (FDA) cleared direct-to-consumer (DTC) test for celiac disease genetics, today announced a commercial …
Powerdyne International Inc. Announces A letter to the Shareholders update
GlobeNewswire
·
May 14, 2025
North Reading, MA, May 14, 2025 (GLOBE NEWSWIRE) -- Powerdyne International, Inc. (Ticker: PWDY) ("Powerdyne" and / or the “Company”) announces A Letter to the Shareholders Update. Dear Shareholders, We would like to thank all our shareholders for their …
INmune Bio Inc. Announces Attendance at the 2025 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
·
May 14, 2025
BOCA RATON, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system, today announces that the Company will be …
Photronics to Report Second Quarter Earnings
GlobeNewswire
·
May 14, 2025
BROOKFIELD, Conn., May 14, 2025 (GLOBE NEWSWIRE) -- Photronics, Inc. (Nasdaq: PLAB), a worldwide leader in photomask technologies and solutions, is scheduled to announce financial results for the second quarter of fiscal 2025 on Wednesday, May 28, 2025, …
DeFi Development Corp. Reports First Quarter 2025 Financial Results and Provides Strategic Update on Solana Treasury Activity
GlobeNewswire
·
May 14, 2025
BOCA RATON, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (“DeFi Dev Corp” or the “Company”), a public-market vehicle focused on long-term Solana (“SOL”) accumulation, today announced financial results for the first quarter …
HEKA AI Mattress Named “Best Overall SleepTech Solution” in 2025 MedTech Breakthrough Awards Program
GlobeNewswire
·
May 14, 2025
LOS ANGELES, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market, today …
NewAmsterdam Pharma to Present at the 2025 RBCCM Global Healthcare Conference
GlobeNewswire
·
May 14, 2025
NAARDEN, The Netherlands and MIAMI, May 14, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …
KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
-- Ongoing patient enrollment in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED); topline data anticipated in 3Q 2025 -- -- Cash resources of $42.2 million as of March 31, 2025, expected to fund operations into 1Q 2026 -- …
Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
GlobeNewswire
·
May 14, 2025
BRISBANE, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced that it will participate …
New Episode Now Streaming on Alpha Liquid Podcast, Bittensor, Decentralizing Artificial Intelligence
GlobeNewswire
·
May 14, 2025
Miami, FL, May 14, 2025 (GLOBE NEWSWIRE) -- Alpha Liquid is pleased to announce the release of Episode 5 of the Alpha Liquid Podcast, featuring an in-depth conversation between host Matthew Mousa and Brody Adreon from TAO Times. This episode dives deep …
Aprea Therapeutics Reports First Quarter 2025 Financial Results and Provides a Clinical Update
GlobeNewswire
·
May 14, 2025
ATRN-119, our ATR inhibitor, exhibits early evidence of single agent, anti-tumor activity and is progressing toward the recommended Phase 2 dose (RP2D) in the ongoing ABOYA-119 clinical trial Three patients in the 550 mg twice daily cohort in the ongoing …
Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights
GlobeNewswire
·
May 14, 2025
Actively enrolling nAMD patients in a Phase 1 trial of TH103, a novel, differentiated anti-VEGF agent engineered to potentially provide longer-lasting and increased anti-VEGF activity to treat neovascular and exudative diseases of the retina; initial …
Indaptus Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
May 14, 2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, today announced financial …
Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO)
GlobeNewswire
·
May 14, 2025
COUNCIL BLUFFS, Iowa, May 14, 2025 (GLOBE NEWSWIRE) -- Sakeer Hussain, MD, a Board-certified medical oncologist at Heartland Oncology and Hematology, a partner practice of the American Oncology Network (AON), has been recognized as a 2025 Advocacy Champion …
Redfin and Magnite Join Forces to Give Advertisers Priority Access to Audience Targeting Across the Homebuying Journey
GlobeNewswire
·
May 14, 2025
NEW YORK, May 14, 2025 (GLOBE NEWSWIRE) -- Redfin (NASDAQ: RDFN), the technology-powered real estate brokerage, has selected Magnite (NASDAQ: MGNI), the largest independent sell-side advertising company, as its preferred SSP to power data-driven deals. …